Gene Symbol | Gene ID | Gene Info |
---|---|---|
Epas1
|
ENSMUSG00000024140.9 | endothelial PAS domain protein 1 |
Bcl3
|
ENSMUSG00000053175.10 | B cell leukemia/lymphoma 3 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr7_19821864_19823009 | Bcl3 | 279 | 0.771780 | -0.54 | 8.5e-06 | Click! |
chr7_19810972_19811715 | Bcl3 | 546 | 0.500007 | 0.43 | 6.9e-04 | Click! |
chr7_19809884_19810197 | Bcl3 | 377 | 0.446660 | 0.32 | 1.3e-02 | Click! |
chr7_19830699_19831081 | Bcl3 | 8120 | 0.071936 | -0.32 | 1.4e-02 | Click! |
chr7_19812685_19812836 | Bcl3 | 73 | 0.919982 | 0.27 | 3.8e-02 | Click! |
chr17_86755778_86755929 | Epas1 | 2153 | 0.295456 | -0.61 | 2.4e-07 | Click! |
chr17_86755996_86756242 | Epas1 | 2419 | 0.273541 | -0.53 | 1.2e-05 | Click! |
chr17_86754645_86755409 | Epas1 | 1327 | 0.429190 | -0.50 | 5.6e-05 | Click! |
chr17_86754057_86754608 | Epas1 | 632 | 0.713414 | -0.46 | 2.2e-04 | Click! |
chr17_86756319_86756959 | Epas1 | 2939 | 0.244502 | -0.42 | 9.0e-04 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr3_80800286_80803016 | 10.79 |
Gria2 |
glutamate receptor, ionotropic, AMPA2 (alpha 2) |
928 |
0.67 |
chr12_88723574_88724074 | 10.42 |
Nrxn3 |
neurexin III |
715 |
0.73 |
chr3_88206822_88208169 | 9.37 |
Gm3764 |
predicted gene 3764 |
183 |
0.86 |
chr1_19215607_19218714 | 9.31 |
Tfap2b |
transcription factor AP-2 beta |
3281 |
0.25 |
chr5_128952013_128953618 | 9.26 |
Rimbp2 |
RIMS binding protein 2 |
218 |
0.95 |
chr4_140245362_140247262 | 8.66 |
Igsf21 |
immunoglobulin superfamily, member 21 |
472 |
0.85 |
chr3_17783692_17784517 | 8.51 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
5817 |
0.2 |
chr2_136711813_136712965 | 8.28 |
Snap25 |
synaptosomal-associated protein 25 |
1064 |
0.55 |
chr2_6881874_6882908 | 8.24 |
Gm13389 |
predicted gene 13389 |
1879 |
0.3 |
chr6_101198088_101199306 | 8.10 |
Gm26911 |
predicted gene, 26911 |
39 |
0.89 |
chr1_42687984_42688646 | 7.93 |
Pantr1 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 |
4778 |
0.15 |
chr5_120433178_120434996 | 7.57 |
Gm27199 |
predicted gene 27199 |
2320 |
0.19 |
chr7_44443183_44443767 | 7.49 |
Lrrc4b |
leucine rich repeat containing 4B |
738 |
0.4 |
chr2_65565600_65566271 | 7.48 |
Scn3a |
sodium channel, voltage-gated, type III, alpha |
1557 |
0.45 |
chr6_36808560_36810410 | 7.38 |
Ptn |
pleiotrophin |
694 |
0.79 |
chr15_25416360_25416622 | 7.24 |
Gm48957 |
predicted gene, 48957 |
1428 |
0.31 |
chrX_100768770_100769163 | 7.17 |
Dlg3 |
discs large MAGUK scaffold protein 3 |
971 |
0.5 |
chr4_128688959_128689777 | 7.08 |
Phc2 |
polyhomeotic 2 |
573 |
0.76 |
chr4_110285468_110287125 | 7.04 |
Elavl4 |
ELAV like RNA binding protein 4 |
320 |
0.94 |
chrX_84076569_84077653 | 7.00 |
Dmd |
dystrophin, muscular dystrophy |
462 |
0.87 |
chr1_77503797_77505059 | 6.81 |
Mir6352 |
microRNA 6352 |
7660 |
0.19 |
chr2_158611997_158612747 | 6.69 |
Gm14205 |
predicted gene 14205 |
552 |
0.57 |
chr16_41533623_41534478 | 6.69 |
Lsamp |
limbic system-associated membrane protein |
631 |
0.84 |
chr1_172025134_172025920 | 6.61 |
Vangl2 |
VANGL planar cell polarity 2 |
1184 |
0.38 |
chr5_88583963_88584847 | 6.54 |
Rufy3 |
RUN and FYVE domain containing 3 |
611 |
0.7 |
chr1_85897395_85899180 | 6.50 |
Itm2c |
integral membrane protein 2C |
3668 |
0.17 |
chr13_83730273_83730487 | 6.30 |
Gm26803 |
predicted gene, 26803 |
798 |
0.49 |
chr3_8509825_8511666 | 6.26 |
Stmn2 |
stathmin-like 2 |
1159 |
0.54 |
chr6_90781027_90782541 | 6.25 |
Iqsec1 |
IQ motif and Sec7 domain 1 |
188 |
0.94 |
chr13_34125172_34126139 | 6.16 |
Tubb2b |
tubulin, beta 2B class IIB |
4699 |
0.12 |
chr11_87759834_87761999 | 6.14 |
Tspoap1 |
TSPO associated protein 1 |
329 |
0.75 |
chr8_108705555_108706511 | 6.05 |
Zfhx3 |
zinc finger homeobox 3 |
2933 |
0.32 |
chr17_93198991_93201483 | 5.93 |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
302 |
0.89 |
chr2_105680581_105683424 | 5.91 |
Pax6 |
paired box 6 |
290 |
0.89 |
chr1_12991432_12992703 | 5.86 |
Slco5a1 |
solute carrier organic anion transporter family, member 5A1 |
583 |
0.78 |
chr8_12398370_12398923 | 5.86 |
Gm25239 |
predicted gene, 25239 |
2243 |
0.21 |
chr9_60686646_60686797 | 5.81 |
Lrrc49 |
leucine rich repeat containing 49 |
813 |
0.64 |
chr1_42703141_42704653 | 5.80 |
Pantr2 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 2 |
4155 |
0.16 |
chr1_66324307_66324676 | 5.71 |
Map2 |
microtubule-associated protein 2 |
2389 |
0.27 |
chr9_91369028_91370469 | 5.65 |
Zic4 |
zinc finger protein of the cerebellum 4 |
250 |
0.86 |
chr2_158606690_158608449 | 5.65 |
Gm14204 |
predicted gene 14204 |
3021 |
0.15 |
chr7_82871690_82872524 | 5.58 |
Mex3b |
mex3 RNA binding family member B |
4774 |
0.17 |
chr19_47016270_47016724 | 5.54 |
Nt5c2 |
5'-nucleotidase, cytosolic II |
1344 |
0.28 |
chrX_152366181_152366965 | 5.50 |
3010001F23Rik |
RIKEN cDNA 3010001F23 gene |
2000 |
0.23 |
chr8_58908783_58909433 | 5.49 |
Galntl6 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 6 |
2468 |
0.31 |
chr15_76519928_76521866 | 5.49 |
Scrt1 |
scratch family zinc finger 1 |
1005 |
0.28 |
chr8_108716860_108718878 | 5.42 |
Zfhx3 |
zinc finger homeobox 3 |
3225 |
0.3 |
chr6_8955848_8957226 | 5.39 |
Nxph1 |
neurexophilin 1 |
6861 |
0.32 |
chrX_134405187_134405491 | 5.34 |
Drp2 |
dystrophin related protein 2 |
537 |
0.77 |
chr13_69737356_69737994 | 5.33 |
Ube2ql1 |
ubiquitin-conjugating enzyme E2Q family-like 1 |
2214 |
0.21 |
chr19_41742559_41744061 | 5.29 |
Slit1 |
slit guidance ligand 1 |
176 |
0.96 |
chr10_80298461_80300404 | 5.23 |
Apc2 |
APC regulator of WNT signaling pathway 2 |
341 |
0.69 |
chr6_55453986_55454137 | 5.22 |
Adcyap1r1 |
adenylate cyclase activating polypeptide 1 receptor 1 |
1884 |
0.37 |
chr13_54748886_54749162 | 5.18 |
Gprin1 |
G protein-regulated inducer of neurite outgrowth 1 |
645 |
0.59 |
chr18_69353016_69353176 | 5.11 |
Tcf4 |
transcription factor 4 |
4152 |
0.31 |
chr7_51623529_51624502 | 5.10 |
Slc17a6 |
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6 |
1133 |
0.51 |
chrX_110815784_110815935 | 5.08 |
Pou3f4 |
POU domain, class 3, transcription factor 4 |
1579 |
0.44 |
chr17_43952337_43954220 | 4.98 |
Rcan2 |
regulator of calcineurin 2 |
27 |
0.99 |
chr6_55680133_55680881 | 4.96 |
Neurod6 |
neurogenic differentiation 6 |
756 |
0.69 |
chr8_54956010_54956394 | 4.95 |
Gpm6a |
glycoprotein m6a |
1359 |
0.38 |
chr8_108706513_108707597 | 4.92 |
Zfhx3 |
zinc finger homeobox 3 |
3955 |
0.29 |
chr14_60380755_60381381 | 4.91 |
Amer2 |
APC membrane recruitment 2 |
2782 |
0.3 |
chr9_26733853_26734637 | 4.90 |
B3gat1 |
beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P) |
394 |
0.83 |
chr9_112232067_112232798 | 4.85 |
Arpp21 |
cyclic AMP-regulated phosphoprotein, 21 |
69 |
0.97 |
chr10_109008310_109009456 | 4.79 |
Syt1 |
synaptotagmin I |
217 |
0.96 |
chr1_66321652_66322390 | 4.77 |
Map2 |
microtubule-associated protein 2 |
23 |
0.98 |
chr6_112946102_112946968 | 4.68 |
Srgap3 |
SLIT-ROBO Rho GTPase activating protein 3 |
219 |
0.74 |
chr14_28508967_28511864 | 4.66 |
Wnt5a |
wingless-type MMTV integration site family, member 5A |
203 |
0.89 |
chrX_101300533_101300752 | 4.64 |
Nlgn3 |
neuroligin 3 |
168 |
0.9 |
chr4_22491084_22492166 | 4.59 |
Gm30731 |
predicted gene, 30731 |
1077 |
0.46 |
chr12_61523440_61524787 | 4.59 |
Lrfn5 |
leucine rich repeat and fibronectin type III domain containing 5 |
165 |
0.95 |
chr6_45059551_45060577 | 4.53 |
Cntnap2 |
contactin associated protein-like 2 |
3 |
0.98 |
chr13_78177509_78178575 | 4.51 |
Gm38604 |
predicted gene, 38604 |
5117 |
0.14 |
chr3_86543379_86544222 | 4.51 |
Lrba |
LPS-responsive beige-like anchor |
1767 |
0.38 |
chr12_67219298_67219500 | 4.47 |
Mdga2 |
MAM domain containing glycosylphosphatidylinositol anchor 2 |
1643 |
0.5 |
chr2_65847409_65848267 | 4.47 |
Csrnp3 |
cysteine-serine-rich nuclear protein 3 |
1983 |
0.36 |
chr9_4794349_4794500 | 4.45 |
Gria4 |
glutamate receptor, ionotropic, AMPA4 (alpha 4) |
1095 |
0.68 |
chr5_117241784_117242411 | 4.41 |
Taok3 |
TAO kinase 3 |
1637 |
0.3 |
chr3_66977838_66980287 | 4.40 |
Shox2 |
short stature homeobox 2 |
251 |
0.9 |
chr7_16131242_16131393 | 4.39 |
Slc8a2 |
solute carrier family 8 (sodium/calcium exchanger), member 2 |
969 |
0.42 |
chr3_88458101_88459325 | 4.36 |
Sema4a |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A |
163 |
0.88 |
chr8_89038877_89039267 | 4.36 |
Sall1 |
spalt like transcription factor 1 |
5090 |
0.25 |
chr7_48960076_48960785 | 4.32 |
Nav2 |
neuron navigator 2 |
1333 |
0.41 |
chr4_125493964_125494986 | 4.30 |
Grik3 |
glutamate receptor, ionotropic, kainate 3 |
3775 |
0.23 |
chr7_4121960_4122900 | 4.29 |
Ttyh1 |
tweety family member 1 |
281 |
0.78 |
chr2_38341551_38341924 | 4.27 |
Lhx2 |
LIM homeobox protein 2 |
645 |
0.64 |
chr10_18470218_18471289 | 4.22 |
Nhsl1 |
NHS-like 1 |
772 |
0.72 |
chr11_108606161_108607110 | 4.22 |
Cep112 |
centrosomal protein 112 |
1408 |
0.5 |
chr10_11081408_11082323 | 4.21 |
Grm1 |
glutamate receptor, metabotropic 1 |
385 |
0.89 |
chr12_15809639_15810314 | 4.19 |
Trib2 |
tribbles pseudokinase 2 |
6809 |
0.16 |
chr3_34638141_34639272 | 4.15 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
202 |
0.53 |
chr1_143643975_143644626 | 4.11 |
Cdc73 |
cell division cycle 73, Paf1/RNA polymerase II complex component |
1775 |
0.33 |
chr17_46486597_46486748 | 4.11 |
Ttbk1 |
tau tubulin kinase 1 |
1003 |
0.36 |
chr6_116056244_116057282 | 4.11 |
Tmcc1 |
transmembrane and coiled coil domains 1 |
192 |
0.94 |
chr17_28040550_28042470 | 4.02 |
Anks1 |
ankyrin repeat and SAM domain containing 1 |
227 |
0.89 |
chr11_69065926_69067384 | 4.01 |
Tmem107 |
transmembrane protein 107 |
4151 |
0.08 |
chr9_21196536_21198489 | 4.01 |
Pde4a |
phosphodiesterase 4A, cAMP specific |
807 |
0.45 |
chr7_34651900_34652206 | 3.99 |
Kctd15 |
potassium channel tetramerisation domain containing 15 |
784 |
0.45 |
chr5_117241509_117241660 | 3.95 |
Taok3 |
TAO kinase 3 |
1124 |
0.42 |
chr7_79498565_79498739 | 3.91 |
Mir9-3hg |
Mir9-3 host gene |
1374 |
0.24 |
chr1_138839332_138840406 | 3.91 |
Lhx9 |
LIM homeobox protein 9 |
2560 |
0.22 |
chr16_5884597_5886147 | 3.90 |
Rbfox1 |
RNA binding protein, fox-1 homolog (C. elegans) 1 |
17 |
0.99 |
chr1_78193153_78194695 | 3.90 |
Pax3 |
paired box 3 |
2914 |
0.3 |
chr4_103620947_103621657 | 3.90 |
Dab1 |
disabled 1 |
1637 |
0.37 |
chr10_87491430_87491970 | 3.89 |
Ascl1 |
achaete-scute family bHLH transcription factor 1 |
1960 |
0.34 |
chr1_77507828_77508329 | 3.86 |
Epha4 |
Eph receptor A4 |
7001 |
0.19 |
chrX_7919510_7921219 | 3.85 |
Pcsk1n |
proprotein convertase subtilisin/kexin type 1 inhibitor |
542 |
0.52 |
chr18_72348735_72348916 | 3.84 |
Dcc |
deleted in colorectal carcinoma |
2192 |
0.45 |
chr17_91091821_91092017 | 3.83 |
Nrxn1 |
neurexin I |
814 |
0.55 |
chr2_71530691_71531882 | 3.80 |
Dlx1 |
distal-less homeobox 1 |
506 |
0.7 |
chr9_121403057_121404479 | 3.75 |
Trak1 |
trafficking protein, kinesin binding 1 |
290 |
0.91 |
chr1_157243489_157244692 | 3.74 |
Rasal2 |
RAS protein activator like 2 |
400 |
0.88 |
chr1_42712788_42712967 | 3.72 |
Pantr2 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 2 |
577 |
0.68 |
chr13_84063384_84064052 | 3.72 |
Gm17750 |
predicted gene, 17750 |
1054 |
0.58 |
chr3_13472761_13473581 | 3.71 |
Ralyl |
RALY RNA binding protein-like |
49 |
0.97 |
chr5_37241461_37244349 | 3.71 |
Crmp1 |
collapsin response mediator protein 1 |
171 |
0.95 |
chr1_6729327_6730832 | 3.71 |
St18 |
suppression of tumorigenicity 18 |
9 |
0.99 |
chr2_62046631_62048214 | 3.69 |
Slc4a10 |
solute carrier family 4, sodium bicarbonate cotransporter-like, member 10 |
777 |
0.76 |
chr3_127225406_127226570 | 3.67 |
Ank2 |
ankyrin 2, brain |
55 |
0.97 |
chr1_160350716_160351791 | 3.67 |
Rabgap1l |
RAB GTPase activating protein 1-like |
318 |
0.88 |
chr5_27261637_27262396 | 3.66 |
Dpp6 |
dipeptidylpeptidase 6 |
41 |
0.98 |
chr6_83171941_83172736 | 3.63 |
Gm15624 |
predicted gene 15624 |
216 |
0.83 |
chr18_60925301_60926809 | 3.61 |
Camk2a |
calcium/calmodulin-dependent protein kinase II alpha |
330 |
0.84 |
chr16_77418973_77419718 | 3.61 |
9430053O09Rik |
RIKEN cDNA 9430053O09 gene |
2475 |
0.17 |
chr2_33637884_33638047 | 3.60 |
Lmx1b |
LIM homeobox transcription factor 1 beta |
2515 |
0.21 |
chr7_79514267_79514939 | 3.59 |
Mir9-3hg |
Mir9-3 host gene |
629 |
0.46 |
chr12_61525470_61525621 | 3.59 |
Lrfn5 |
leucine rich repeat and fibronectin type III domain containing 5 |
1597 |
0.38 |
chr2_181768465_181769553 | 3.58 |
Myt1 |
myelin transcription factor 1 |
1497 |
0.33 |
chr17_80946268_80946852 | 3.57 |
Tmem178 |
transmembrane protein 178 |
1928 |
0.35 |
chr14_19974553_19975713 | 3.57 |
Gng2 |
guanine nucleotide binding protein (G protein), gamma 2 |
1560 |
0.43 |
chr1_12988619_12989682 | 3.56 |
Slco5a1 |
solute carrier organic anion transporter family, member 5A1 |
1764 |
0.4 |
chr9_89622321_89623623 | 3.56 |
Minar1 |
membrane integral NOTCH2 associated receptor 1 |
153 |
0.95 |
chr1_42693836_42695485 | 3.56 |
Pantr1 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 |
148 |
0.5 |
chr15_99670221_99671432 | 3.55 |
Asic1 |
acid-sensing (proton-gated) ion channel 1 |
458 |
0.66 |
chr11_74589375_74590721 | 3.54 |
Rap1gap2 |
RAP1 GTPase activating protein 2 |
76 |
0.97 |
chr11_114794635_114794844 | 3.54 |
Btbd17 |
BTB (POZ) domain containing 17 |
1134 |
0.38 |
chr7_99465733_99467458 | 3.53 |
Klhl35 |
kelch-like 35 |
591 |
0.6 |
chr9_91368264_91368717 | 3.52 |
Zic4 |
zinc finger protein of the cerebellum 4 |
123 |
0.93 |
chr2_18051288_18051879 | 3.52 |
Skida1 |
SKI/DACH domain containing 1 |
2532 |
0.15 |
chr10_109010445_109010974 | 3.51 |
Syt1 |
synaptotagmin I |
253 |
0.95 |
chr7_144132849_144134003 | 3.51 |
Gm44999 |
predicted gene 44999 |
22341 |
0.2 |
chr18_72349127_72350542 | 3.51 |
Dcc |
deleted in colorectal carcinoma |
1183 |
0.64 |
chr13_78175967_78177173 | 3.51 |
3110006O06Rik |
RIKEN cDNA 3110006O06 gene |
4940 |
0.15 |
chr5_34550299_34550725 | 3.49 |
Sh3bp2 |
SH3-domain binding protein 2 |
824 |
0.45 |
chr1_66386919_66387899 | 3.49 |
Map2 |
microtubule-associated protein 2 |
398 |
0.87 |
chr4_42173585_42174168 | 3.46 |
1700045I11Rik |
RIKEN cDNA 1700045I11 gene |
3031 |
0.11 |
chr13_83722679_83723219 | 3.43 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
1568 |
0.29 |
chr9_62783166_62783770 | 3.43 |
Gm7653 |
predicted gene 7653 |
6436 |
0.18 |
chr6_94695739_94697689 | 3.43 |
Lrig1 |
leucine-rich repeats and immunoglobulin-like domains 1 |
3423 |
0.29 |
chr10_106469534_106470969 | 3.42 |
Ppfia2 |
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 2 |
88 |
0.97 |
chr2_74713881_74716227 | 3.40 |
Hoxd3os1 |
homeobox D3, opposite strand 1 |
942 |
0.23 |
chr5_120425610_120425983 | 3.40 |
Lhx5 |
LIM homeobox protein 5 |
5903 |
0.14 |
chr4_124880880_124881256 | 3.38 |
Epha10 |
Eph receptor A10 |
169 |
0.91 |
chr5_111429061_111430219 | 3.35 |
Gm43119 |
predicted gene 43119 |
6051 |
0.18 |
chr1_66323360_66324079 | 3.33 |
Map2 |
microtubule-associated protein 2 |
1617 |
0.37 |
chr14_122484555_122484706 | 3.32 |
Gm10837 |
predicted gene 10837 |
5956 |
0.11 |
chr5_116590520_116593206 | 3.31 |
Srrm4 |
serine/arginine repetitive matrix 4 |
46 |
0.98 |
chr7_119184137_119185474 | 3.30 |
Gpr139 |
G protein-coupled receptor 139 |
202 |
0.96 |
chr6_54565340_54565491 | 3.29 |
Scrn1 |
secernin 1 |
1074 |
0.49 |
chr9_122573626_122573896 | 3.29 |
9530059O14Rik |
RIKEN cDNA 9530059O14 gene |
1259 |
0.39 |
chr11_112784278_112785462 | 3.29 |
Sox9 |
SRY (sex determining region Y)-box 9 |
2646 |
0.24 |
chr7_44336079_44337576 | 3.28 |
Shank1 |
SH3 and multiple ankyrin repeat domains 1 |
811 |
0.34 |
chr7_4120918_4121688 | 3.26 |
9430041J12Rik |
RIKEN cDNA 9430041J12 gene |
575 |
0.45 |
chr16_77647989_77648514 | 3.26 |
C130023A14Rik |
RIKEN cDNA C130023A14 gene |
1911 |
0.18 |
chr3_84952327_84953098 | 3.24 |
Fbxw7 |
F-box and WD-40 domain protein 7 |
566 |
0.84 |
chr2_94247535_94247727 | 3.23 |
Mir670hg |
MIR670 host gene (non-protein coding) |
4293 |
0.16 |
chr2_116056837_116059755 | 3.23 |
Meis2 |
Meis homeobox 2 |
546 |
0.75 |
chr13_88822801_88824341 | 3.22 |
Edil3 |
EGF-like repeats and discoidin I-like domains 3 |
1929 |
0.5 |
chr14_98166607_98166990 | 3.22 |
Dach1 |
dachshund family transcription factor 1 |
2745 |
0.34 |
chr11_42419852_42421693 | 3.19 |
Gabrb2 |
gamma-aminobutyric acid (GABA) A receptor, subunit beta 2 |
507 |
0.88 |
chr13_97243599_97244237 | 3.19 |
Enc1 |
ectodermal-neural cortex 1 |
2813 |
0.23 |
chr5_69339273_69339497 | 3.19 |
Gm24368 |
predicted gene, 24368 |
1398 |
0.32 |
chr2_152080491_152081480 | 3.18 |
Scrt2 |
scratch family zinc finger 2 |
544 |
0.7 |
chr12_15812207_15812700 | 3.18 |
Trib2 |
tribbles pseudokinase 2 |
4332 |
0.17 |
chr1_78188074_78188656 | 3.17 |
Pax3 |
paired box 3 |
8473 |
0.23 |
chr9_41585694_41587243 | 3.17 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
1301 |
0.29 |
chr7_94042433_94043470 | 3.16 |
Gm32647 |
predicted gene, 32647 |
199 |
0.97 |
chr2_65622009_65622167 | 3.14 |
Scn2a |
sodium channel, voltage-gated, type II, alpha |
1277 |
0.54 |
chr3_34561815_34562105 | 3.14 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
1568 |
0.33 |
chr18_25751839_25752425 | 3.14 |
Celf4 |
CUGBP, Elav-like family member 4 |
560 |
0.81 |
chr11_98325707_98326374 | 3.14 |
Neurod2 |
neurogenic differentiation 2 |
3608 |
0.12 |
chr8_67817715_67818694 | 3.12 |
Psd3 |
pleckstrin and Sec7 domain containing 3 |
29 |
0.99 |
chr16_77235848_77236417 | 3.12 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
185 |
0.96 |
chr2_137808687_137808974 | 3.12 |
Gm14062 |
predicted gene 14062 |
68001 |
0.14 |
chr13_58807413_58808951 | 3.11 |
Ntrk2 |
neurotrophic tyrosine kinase, receptor, type 2 |
99 |
0.95 |
chr10_19354370_19355680 | 3.11 |
Olig3 |
oligodendrocyte transcription factor 3 |
1508 |
0.47 |
chr5_137733707_137734375 | 3.11 |
Nyap1 |
neuronal tyrosine-phosphorylated phosphoinositide 3-kinase adaptor 1 |
5677 |
0.09 |
chr9_98968051_98968202 | 3.10 |
Foxl2os |
forkhead box L2, opposite strand |
12827 |
0.11 |
chr19_41739688_41740472 | 3.10 |
Slit1 |
slit guidance ligand 1 |
3406 |
0.26 |
chr2_158606104_158606672 | 3.09 |
Gm14204 |
predicted gene 14204 |
4202 |
0.13 |
chr14_67236008_67239452 | 3.08 |
Ebf2 |
early B cell factor 2 |
3086 |
0.21 |
chr7_101422402_101423202 | 3.06 |
Pde2a |
phosphodiesterase 2A, cGMP-stimulated |
956 |
0.45 |
chr4_42670348_42671327 | 3.06 |
Il11ra2 |
interleukin 11 receptor, alpha chain 2 |
5074 |
0.14 |
chr6_39870435_39871218 | 3.06 |
Tmem178b |
transmembrane protein 178B |
635 |
0.56 |
chr11_96321777_96323051 | 3.05 |
Hoxb3 |
homeobox B3 |
912 |
0.3 |
chr7_25153391_25155013 | 3.01 |
D930028M14Rik |
RIKEN cDNA D930028M14 gene |
867 |
0.45 |
chr4_148131484_148131792 | 3.00 |
Mad2l2 |
MAD2 mitotic arrest deficient-like 2 |
723 |
0.38 |
chr1_172017488_172018115 | 3.00 |
Vangl2 |
VANGL planar cell polarity 2 |
8772 |
0.14 |
chr6_6878154_6880927 | 2.99 |
Dlx5 |
distal-less homeobox 5 |
2528 |
0.19 |
chr18_64265051_64265782 | 2.99 |
St8sia3 |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3 |
570 |
0.71 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 11.2 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
2.7 | 8.0 | GO:0061341 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
2.4 | 7.1 | GO:0021553 | olfactory nerve development(GO:0021553) |
2.2 | 6.6 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
2.0 | 8.1 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
2.0 | 6.0 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
1.9 | 5.7 | GO:2000809 | positive regulation of synaptic vesicle clustering(GO:2000809) |
1.9 | 5.6 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
1.8 | 5.5 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
1.8 | 7.3 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
1.7 | 6.8 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
1.5 | 4.6 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
1.5 | 4.5 | GO:1990034 | calcium ion export from cell(GO:1990034) |
1.5 | 4.5 | GO:0048880 | sensory system development(GO:0048880) |
1.4 | 4.2 | GO:0046684 | response to pyrethroid(GO:0046684) |
1.4 | 8.3 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
1.4 | 4.1 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
1.3 | 3.8 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
1.2 | 5.0 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
1.2 | 16.9 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
1.2 | 2.3 | GO:0007386 | compartment pattern specification(GO:0007386) |
1.1 | 3.4 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
1.1 | 5.7 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
1.1 | 3.4 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
1.1 | 4.3 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
1.1 | 3.2 | GO:0060594 | mammary gland specification(GO:0060594) |
1.1 | 4.2 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
1.0 | 13.6 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
1.0 | 4.1 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
1.0 | 3.0 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
1.0 | 6.8 | GO:0005513 | detection of calcium ion(GO:0005513) |
1.0 | 5.9 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
1.0 | 8.8 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
0.9 | 4.6 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
0.9 | 1.8 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.9 | 1.8 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
0.8 | 7.5 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.8 | 4.1 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.8 | 2.5 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.8 | 2.4 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.8 | 2.3 | GO:2000053 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) |
0.8 | 4.5 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.7 | 1.5 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.7 | 1.5 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.7 | 2.2 | GO:0097503 | sialylation(GO:0097503) |
0.7 | 7.9 | GO:0007614 | short-term memory(GO:0007614) |
0.7 | 10.0 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.7 | 2.8 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.7 | 4.6 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.7 | 4.6 | GO:0071625 | vocalization behavior(GO:0071625) |
0.7 | 2.0 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.6 | 0.6 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.6 | 1.8 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.6 | 0.6 | GO:2000040 | regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
0.6 | 4.8 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.6 | 2.4 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.6 | 1.8 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.6 | 1.2 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
0.6 | 1.2 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.6 | 1.2 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.6 | 2.3 | GO:0007412 | axon target recognition(GO:0007412) |
0.6 | 1.7 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.6 | 2.3 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.6 | 8.4 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.6 | 7.7 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.5 | 1.1 | GO:0072193 | ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
0.5 | 1.6 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.5 | 1.6 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
0.5 | 0.5 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.5 | 1.5 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.5 | 6.6 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.5 | 5.5 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.5 | 7.5 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.5 | 3.5 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.5 | 0.5 | GO:0043266 | regulation of potassium ion transport(GO:0043266) |
0.5 | 0.5 | GO:0036486 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
0.5 | 1.4 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.5 | 1.9 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.5 | 0.5 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.5 | 3.8 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.5 | 3.7 | GO:0060013 | righting reflex(GO:0060013) |
0.5 | 0.9 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.5 | 1.4 | GO:0015888 | thiamine transport(GO:0015888) |
0.4 | 0.9 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.4 | 2.2 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.4 | 2.2 | GO:0072017 | distal tubule development(GO:0072017) |
0.4 | 0.9 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.4 | 1.8 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.4 | 1.3 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.4 | 0.4 | GO:0060174 | limb bud formation(GO:0060174) |
0.4 | 0.8 | GO:0060166 | olfactory pit development(GO:0060166) |
0.4 | 1.2 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.4 | 0.8 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.4 | 1.2 | GO:0021826 | substrate-independent telencephalic tangential migration(GO:0021826) substrate-independent telencephalic tangential interneuron migration(GO:0021843) |
0.4 | 1.2 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.4 | 1.2 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.4 | 1.2 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.4 | 1.2 | GO:0072695 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.4 | 17.8 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.4 | 1.9 | GO:0060023 | soft palate development(GO:0060023) |
0.4 | 1.5 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.4 | 0.8 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.4 | 0.8 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.4 | 3.4 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.4 | 0.7 | GO:0021779 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.4 | 3.0 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.4 | 1.1 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.4 | 1.5 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.4 | 1.8 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.4 | 1.1 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.4 | 10.9 | GO:0019228 | neuronal action potential(GO:0019228) |
0.4 | 0.4 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.4 | 4.6 | GO:0001964 | startle response(GO:0001964) |
0.4 | 1.4 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.4 | 4.6 | GO:0060384 | innervation(GO:0060384) |
0.4 | 2.8 | GO:0001975 | response to amphetamine(GO:0001975) |
0.3 | 17.5 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.3 | 0.7 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.3 | 10.7 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.3 | 1.0 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.3 | 1.4 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.3 | 1.4 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.3 | 1.7 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.3 | 0.3 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
0.3 | 2.3 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.3 | 1.0 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.3 | 2.0 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.3 | 0.7 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.3 | 1.0 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.3 | 0.7 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.3 | 1.0 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.3 | 0.6 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.3 | 0.6 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.3 | 1.2 | GO:1903421 | regulation of synaptic vesicle recycling(GO:1903421) |
0.3 | 0.6 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.3 | 0.6 | GO:0021877 | forebrain neuron fate commitment(GO:0021877) |
0.3 | 1.5 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.3 | 2.0 | GO:0061001 | regulation of dendritic spine morphogenesis(GO:0061001) |
0.3 | 0.3 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.3 | 1.4 | GO:0061042 | vascular wound healing(GO:0061042) |
0.3 | 9.9 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
0.3 | 0.3 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.3 | 1.4 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.3 | 0.8 | GO:0001546 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.3 | 0.5 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.3 | 0.8 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.3 | 2.4 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.3 | 4.4 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.3 | 3.6 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.3 | 3.3 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.3 | 0.5 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.3 | 0.8 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.3 | 3.0 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.3 | 1.5 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.2 | 2.0 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.2 | 0.5 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.2 | 2.0 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.2 | 0.5 | GO:0051464 | positive regulation of cortisol secretion(GO:0051464) |
0.2 | 0.5 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.2 | 0.5 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.2 | 0.7 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
0.2 | 0.9 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.2 | 0.5 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.2 | 2.3 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.2 | 1.6 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.2 | 3.7 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.2 | 4.8 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.2 | 0.9 | GO:0090135 | actin filament branching(GO:0090135) |
0.2 | 1.1 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
0.2 | 1.1 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.2 | 1.6 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.2 | 6.3 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.2 | 0.7 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.2 | 0.7 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.2 | 0.7 | GO:0021794 | thalamus development(GO:0021794) |
0.2 | 4.4 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.2 | 0.4 | GO:0014858 | positive regulation of skeletal muscle cell proliferation(GO:0014858) |
0.2 | 3.7 | GO:0030823 | regulation of cGMP metabolic process(GO:0030823) |
0.2 | 3.3 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.2 | 0.4 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.2 | 14.5 | GO:0001764 | neuron migration(GO:0001764) |
0.2 | 0.6 | GO:0033504 | floor plate development(GO:0033504) |
0.2 | 0.9 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.2 | 0.4 | GO:1904688 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.2 | 0.4 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.2 | 1.3 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.2 | 9.1 | GO:1900006 | positive regulation of dendrite development(GO:1900006) |
0.2 | 3.6 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.2 | 14.3 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.2 | 1.3 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.2 | 0.4 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.2 | 1.7 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.2 | 2.7 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.2 | 1.0 | GO:0035308 | negative regulation of protein dephosphorylation(GO:0035308) |
0.2 | 0.6 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.2 | 0.4 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.2 | 0.4 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.2 | 0.2 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.2 | 0.6 | GO:0021612 | facial nerve structural organization(GO:0021612) |
0.2 | 1.2 | GO:0050957 | equilibrioception(GO:0050957) |
0.2 | 0.4 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.2 | 0.2 | GO:2000739 | regulation of mesenchymal stem cell differentiation(GO:2000739) |
0.2 | 0.2 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.2 | 0.4 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.2 | 0.6 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.2 | 0.2 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.2 | 0.8 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
0.2 | 0.4 | GO:0045297 | mating plug formation(GO:0042628) post-mating behavior(GO:0045297) |
0.2 | 0.6 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.2 | 1.0 | GO:0001956 | positive regulation of neurotransmitter secretion(GO:0001956) positive regulation of neurotransmitter transport(GO:0051590) |
0.2 | 0.4 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.2 | 3.0 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
0.2 | 1.1 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.2 | 3.0 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.2 | 1.8 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.2 | 1.1 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.2 | 1.7 | GO:0015816 | glycine transport(GO:0015816) |
0.2 | 0.4 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.2 | 1.3 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.2 | 0.2 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.2 | 2.6 | GO:0006828 | manganese ion transport(GO:0006828) |
0.2 | 1.3 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.2 | 1.3 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.2 | 0.9 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.2 | 0.9 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.2 | 0.4 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.2 | 1.8 | GO:0007616 | long-term memory(GO:0007616) |
0.2 | 0.2 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.2 | 0.2 | GO:0048841 | regulation of axon extension involved in axon guidance(GO:0048841) regulation of axon guidance(GO:1902667) |
0.2 | 0.7 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.2 | 0.4 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.2 | 0.9 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.2 | 0.5 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.2 | 0.5 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.2 | 0.2 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.2 | 0.5 | GO:0042637 | catagen(GO:0042637) |
0.2 | 0.2 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) |
0.2 | 1.2 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.2 | 0.5 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.2 | 1.1 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.2 | 1.0 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.2 | 0.5 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.2 | 0.8 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.2 | 0.5 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.2 | 1.0 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.2 | 10.9 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.2 | 0.3 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.2 | 1.1 | GO:0006337 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.2 | 0.3 | GO:0072033 | renal vesicle formation(GO:0072033) |
0.2 | 0.8 | GO:0033762 | response to glucagon(GO:0033762) |
0.2 | 0.5 | GO:0030432 | peristalsis(GO:0030432) |
0.2 | 0.2 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.2 | 0.5 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.2 | 2.0 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.1 | 0.6 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.1 | 0.6 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.1 | 1.3 | GO:0048814 | regulation of dendrite morphogenesis(GO:0048814) |
0.1 | 4.0 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 0.6 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.1 | 1.0 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.1 | 0.1 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.1 | 0.6 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
0.1 | 0.4 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.1 | 0.3 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) |
0.1 | 1.0 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.1 | 0.4 | GO:0060278 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
0.1 | 0.4 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.1 | 0.5 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.1 | 0.3 | GO:1904587 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.1 | 0.4 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.1 | 0.3 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.1 | 2.3 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.1 | 0.4 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.1 | 0.1 | GO:0043465 | regulation of fermentation(GO:0043465) regulation of NAD metabolic process(GO:1902688) regulation of glucose catabolic process to lactate via pyruvate(GO:1904023) |
0.1 | 0.3 | GO:2000347 | positive regulation of hepatocyte proliferation(GO:2000347) |
0.1 | 1.3 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 0.4 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.1 | 0.4 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.1 | 0.4 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.1 | 0.6 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.1 | 0.1 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) |
0.1 | 0.3 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.1 | 0.1 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
0.1 | 0.1 | GO:0003139 | secondary heart field specification(GO:0003139) |
0.1 | 0.1 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.1 | 0.1 | GO:0010796 | regulation of multivesicular body size(GO:0010796) regulation of endosome size(GO:0051036) |
0.1 | 0.1 | GO:0060872 | semicircular canal morphogenesis(GO:0048752) semicircular canal development(GO:0060872) |
0.1 | 0.4 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.1 | 0.5 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.1 | 0.2 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.1 | 0.2 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.1 | 0.9 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.1 | 0.2 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.1 | 0.4 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 0.4 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.7 | GO:1902222 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.1 | 0.5 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.1 | 0.2 | GO:0042519 | tyrosine phosphorylation of Stat4 protein(GO:0042504) regulation of tyrosine phosphorylation of Stat4 protein(GO:0042519) |
0.1 | 3.6 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.1 | 1.6 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.1 | 0.2 | GO:0035907 | dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
0.1 | 0.2 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.1 | 0.9 | GO:0008306 | associative learning(GO:0008306) |
0.1 | 0.3 | GO:0061081 | positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
0.1 | 0.1 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
0.1 | 0.1 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.1 | 0.1 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.1 | 0.5 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 0.4 | GO:0035989 | tendon development(GO:0035989) |
0.1 | 0.8 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.1 | 0.4 | GO:1900040 | regulation of interleukin-2 secretion(GO:1900040) positive regulation of interleukin-2 secretion(GO:1900042) |
0.1 | 0.2 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
0.1 | 0.4 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.1 | 0.4 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.1 | 0.7 | GO:1900107 | regulation of nodal signaling pathway(GO:1900107) |
0.1 | 0.2 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.1 | 0.1 | GO:0061205 | paramesonephric duct development(GO:0061205) |
0.1 | 0.2 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.1 | 2.4 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.1 | 0.3 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.1 | 0.3 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.1 | 0.5 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 1.1 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 0.1 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.1 | 1.5 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 1.3 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.1 | 0.3 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.1 | 1.6 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.1 | 0.1 | GO:0036257 | multivesicular body organization(GO:0036257) |
0.1 | 0.2 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.1 | 0.1 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.1 | 1.4 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.4 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.8 | GO:1990118 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.1 | 1.0 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.1 | 0.4 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.1 | 0.1 | GO:0060745 | mammary gland branching involved in pregnancy(GO:0060745) tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.1 | 0.5 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.1 | 0.1 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.1 | 1.1 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.1 | 0.1 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 1.6 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.1 | 1.1 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.1 | 0.2 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.1 | 0.1 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.1 | 0.1 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.1 | 0.1 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.1 | 0.2 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
0.1 | 0.4 | GO:0046618 | drug export(GO:0046618) |
0.1 | 0.3 | GO:0021854 | hypothalamus development(GO:0021854) |
0.1 | 0.3 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.1 | 0.3 | GO:0051466 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.1 | 0.5 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 2.2 | GO:0008542 | visual learning(GO:0008542) |
0.1 | 0.3 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.1 | 0.1 | GO:0086015 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
0.1 | 0.2 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.1 | 0.9 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 0.1 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.1 | 0.5 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.1 | 0.4 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.1 | 0.2 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.1 | 3.3 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.1 | 1.0 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.1 | 0.6 | GO:1901160 | primary amino compound metabolic process(GO:1901160) |
0.1 | 0.1 | GO:0021783 | preganglionic parasympathetic fiber development(GO:0021783) |
0.1 | 0.7 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.1 | 0.8 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.1 | 0.2 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.1 | 0.2 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 0.2 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.1 | 2.0 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.2 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.1 | 1.6 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.1 | 0.2 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.1 | 0.3 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.1 | 3.9 | GO:0010977 | negative regulation of neuron projection development(GO:0010977) |
0.1 | 0.2 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.1 | 0.2 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.1 | 0.2 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.1 | 0.3 | GO:0071907 | determination of digestive tract left/right asymmetry(GO:0071907) |
0.1 | 0.1 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.1 | 1.1 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.1 | 0.2 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.1 | 0.4 | GO:0006116 | NADH oxidation(GO:0006116) |
0.1 | 0.4 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.1 | 0.1 | GO:0031498 | chromatin disassembly(GO:0031498) |
0.1 | 0.3 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.1 | 0.3 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 0.8 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.1 | 0.3 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.1 | 0.3 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 0.3 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.1 | 0.2 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.1 | 0.5 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 0.3 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 0.2 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.1 | 0.4 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 0.2 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.1 | 0.9 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.1 | 0.3 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 1.1 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.1 | 0.2 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.1 | 0.2 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
0.1 | 1.0 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 0.2 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.6 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.1 | 0.1 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.1 | 0.2 | GO:0070175 | positive regulation of enamel mineralization(GO:0070175) |
0.1 | 0.2 | GO:0090427 | activation of meiosis(GO:0090427) |
0.1 | 0.4 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.1 | 0.3 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 | 0.2 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.1 | 0.2 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
0.1 | 0.1 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.1 | 0.1 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.1 | 0.2 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.1 | 0.2 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 0.1 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.1 | 0.2 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.1 | 0.3 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.1 | 0.3 | GO:0048664 | neuron fate determination(GO:0048664) |
0.1 | 0.1 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.1 | 1.2 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 0.1 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.1 | 0.3 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.1 | 0.4 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.1 | 1.7 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.1 | 0.1 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 0.2 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.1 | 0.1 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.1 | 0.4 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.1 | GO:0001555 | oocyte growth(GO:0001555) |
0.1 | 0.1 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.1 | 0.8 | GO:1990138 | neuron projection extension(GO:1990138) |
0.1 | 0.2 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.1 | 0.2 | GO:0010455 | positive regulation of cell fate commitment(GO:0010455) |
0.1 | 0.4 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.1 | 0.2 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.1 | 0.1 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.1 | 0.2 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.1 | 0.3 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.1 | 0.1 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.1 | 0.3 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.1 | 0.6 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.1 | GO:0021578 | hindbrain maturation(GO:0021578) central nervous system maturation(GO:0021626) |
0.1 | 0.8 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.1 | 0.3 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.1 | 0.1 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.1 | 0.1 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.1 | 0.1 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.1 | 0.3 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.1 | 0.3 | GO:0098764 | meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
0.1 | 0.5 | GO:0001662 | behavioral fear response(GO:0001662) |
0.1 | 0.2 | GO:0019086 | late viral transcription(GO:0019086) |
0.1 | 0.1 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.1 | 0.6 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.1 | 0.3 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 0.1 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.1 | 0.1 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.1 | 0.2 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.1 | 0.4 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.1 | 0.1 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.1 | 0.2 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.1 | 0.3 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.1 | 1.2 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.2 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 0.1 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
0.1 | 0.3 | GO:0070417 | cellular response to cold(GO:0070417) |
0.1 | 0.1 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 0.2 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 0.1 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.1 | 0.1 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.1 | 0.1 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.1 | 0.1 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 0.2 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.1 | 0.5 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.1 | 0.1 | GO:2000794 | regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) |
0.1 | 0.2 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.1 | 0.1 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.1 | 0.1 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
0.1 | 0.1 | GO:0031446 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.1 | 0.5 | GO:0021766 | hippocampus development(GO:0021766) |
0.1 | 0.5 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.1 | 0.4 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 0.2 | GO:0018101 | protein citrullination(GO:0018101) |
0.1 | 1.1 | GO:0015844 | monoamine transport(GO:0015844) |
0.1 | 0.6 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.2 | GO:0010288 | response to lead ion(GO:0010288) |
0.1 | 0.3 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.1 | 0.2 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.1 | 0.1 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.1 | 0.3 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 1.4 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.1 | 0.2 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.1 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.1 | 0.5 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.1 | 0.2 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.1 | 0.1 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.1 | 0.1 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.1 | 0.2 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.1 | 0.1 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.1 | 0.1 | GO:2000668 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
0.1 | 0.1 | GO:0061548 | ganglion development(GO:0061548) |
0.1 | 0.4 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.1 | 0.5 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.1 | 0.2 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.0 | 2.1 | GO:0099531 | presynaptic process involved in chemical synaptic transmission(GO:0099531) |
0.0 | 0.2 | GO:0061037 | negative regulation of cartilage development(GO:0061037) |
0.0 | 0.0 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.0 | 0.1 | GO:0003352 | regulation of cilium movement(GO:0003352) |
0.0 | 0.4 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.0 | 0.0 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.0 | 0.1 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.0 | 0.1 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.0 | 0.0 | GO:0072679 | thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
0.0 | 0.0 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.0 | 0.0 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.0 | 0.5 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.0 | 0.0 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) |
0.0 | 0.4 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.0 | 0.1 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.0 | 0.0 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.0 | 1.0 | GO:0050832 | defense response to fungus(GO:0050832) |
0.0 | 0.2 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.0 | 0.0 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.1 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.0 | 0.1 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
0.0 | 1.8 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.0 | 0.1 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.0 | 0.2 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.0 | 0.6 | GO:0022011 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.0 | 0.0 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.0 | 0.2 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.0 | 0.2 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.0 | 0.6 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.0 | 0.1 | GO:0008228 | opsonization(GO:0008228) |
0.0 | 0.2 | GO:0046836 | glycolipid transport(GO:0046836) |
0.0 | 0.1 | GO:0072396 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
0.0 | 0.1 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.0 | 0.2 | GO:0035729 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.0 | 0.2 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.0 | 0.1 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.0 | 0.1 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.0 | 0.2 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.0 | 0.1 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.0 | 0.0 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.0 | 0.1 | GO:0042048 | olfactory behavior(GO:0042048) |
0.0 | 0.1 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.0 | 0.1 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.0 | 0.2 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.0 | 0.0 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.0 | 0.5 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.0 | 0.2 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.1 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.0 | 0.7 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.0 | 0.2 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.0 | 0.1 | GO:0009642 | response to light intensity(GO:0009642) |
0.0 | 0.5 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
0.0 | 0.1 | GO:0010893 | positive regulation of steroid biosynthetic process(GO:0010893) |
0.0 | 0.1 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.0 | 0.2 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.0 | 0.0 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.0 | 0.3 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.0 | 0.1 | GO:0002634 | regulation of germinal center formation(GO:0002634) |
0.0 | 0.2 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.0 | 0.4 | GO:0042755 | eating behavior(GO:0042755) |
0.0 | 0.1 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.0 | 0.0 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.0 | 0.3 | GO:1990403 | embryonic brain development(GO:1990403) |
0.0 | 0.2 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.0 | 0.2 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.1 | GO:0048254 | snoRNA localization(GO:0048254) |
0.0 | 0.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.2 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.0 | 0.3 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.0 | 0.3 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.0 | 0.1 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.0 | 0.2 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.0 | 0.1 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.0 | 0.1 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.0 | 0.1 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.0 | 0.0 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.0 | 0.1 | GO:0014028 | notochord formation(GO:0014028) |
0.0 | 1.7 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.6 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.0 | 0.1 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.0 | 0.1 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.0 | 0.0 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.0 | 0.1 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.0 | 0.1 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) regulation of follicle-stimulating hormone secretion(GO:0046880) negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.0 | 0.0 | GO:0071609 | chemokine (C-C motif) ligand 5 production(GO:0071609) |
0.0 | 0.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.0 | 0.7 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
0.0 | 0.0 | GO:0098739 | import across plasma membrane(GO:0098739) amino acid import into cell(GO:1902837) |
0.0 | 0.8 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.0 | 0.0 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.0 | 0.1 | GO:0071435 | potassium ion export(GO:0071435) |
0.0 | 0.1 | GO:0060179 | male mating behavior(GO:0060179) |
0.0 | 0.5 | GO:0032350 | regulation of hormone metabolic process(GO:0032350) |
0.0 | 0.1 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.0 | 0.4 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.0 | 0.2 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.1 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.0 | 0.1 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.0 | 0.3 | GO:0097576 | vacuole fusion(GO:0097576) |
0.0 | 0.0 | GO:0070640 | vitamin D3 metabolic process(GO:0070640) |
0.0 | 0.1 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.0 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 0.1 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.0 | 0.3 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 0.1 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.0 | 0.0 | GO:0051350 | negative regulation of lyase activity(GO:0051350) |
0.0 | 0.1 | GO:0090155 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.0 | 0.1 | GO:0015744 | succinate transport(GO:0015744) |
0.0 | 0.0 | GO:0072566 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
0.0 | 0.1 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.0 | 0.1 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.0 | 0.2 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.2 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.0 | 0.0 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.0 | 0.2 | GO:1901299 | negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
0.0 | 0.3 | GO:0050716 | positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
0.0 | 0.1 | GO:2000319 | regulation of T-helper 17 cell differentiation(GO:2000319) |
0.0 | 0.1 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.0 | 0.2 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
0.0 | 0.2 | GO:0031103 | axon regeneration(GO:0031103) |
0.0 | 0.3 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.0 | 0.1 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.0 | 0.0 | GO:0050686 | negative regulation of mRNA processing(GO:0050686) |
0.0 | 0.0 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.0 | 0.2 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.0 | 0.1 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.0 | 0.1 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.0 | 0.1 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.0 | 0.1 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.0 | 0.1 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.0 | 0.4 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
0.0 | 0.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.0 | 0.1 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.0 | 0.1 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.0 | 0.3 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.0 | 0.2 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.0 | 0.1 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.0 | 0.1 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.0 | 0.4 | GO:0032401 | establishment of melanosome localization(GO:0032401) establishment of pigment granule localization(GO:0051905) |
0.0 | 0.1 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.0 | 0.7 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.0 | 0.1 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.0 | 0.4 | GO:0060964 | regulation of gene silencing by miRNA(GO:0060964) |
0.0 | 0.0 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.0 | 0.1 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.0 | 0.2 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.0 | 0.3 | GO:0050654 | chondroitin sulfate proteoglycan metabolic process(GO:0050654) |
0.0 | 0.0 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.0 | 0.1 | GO:0015886 | heme transport(GO:0015886) |
0.0 | 0.1 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.0 | 0.1 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.0 | 0.4 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.0 | 0.0 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.0 | 0.2 | GO:0090399 | replicative senescence(GO:0090399) |
0.0 | 0.1 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.0 | 0.0 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.0 | 0.1 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.0 | 0.2 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.0 | 0.0 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.0 | 0.1 | GO:0051181 | cofactor transport(GO:0051181) |
0.0 | 0.1 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.0 | 0.0 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.0 | 0.1 | GO:1903206 | negative regulation of hydrogen peroxide-induced cell death(GO:1903206) |
0.0 | 0.1 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.0 | 0.0 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.0 | 0.0 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.1 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.0 | 0.1 | GO:0051031 | tRNA transport(GO:0051031) |
0.0 | 0.0 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.0 | 0.1 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.0 | 0.2 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.0 | 0.0 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.0 | 0.0 | GO:0008038 | neuron recognition(GO:0008038) |
0.0 | 0.1 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
0.0 | 0.2 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.0 | 0.1 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.0 | 0.4 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.0 | 0.1 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.0 | 0.3 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.0 | 0.2 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.0 | 0.1 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.0 | 0.0 | GO:0090148 | membrane fission(GO:0090148) |
0.0 | 0.5 | GO:0050770 | regulation of axonogenesis(GO:0050770) |
0.0 | 0.1 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.0 | 0.0 | GO:0014044 | Schwann cell development(GO:0014044) |
0.0 | 0.1 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.0 | 0.0 | GO:0036490 | regulation of translation in response to endoplasmic reticulum stress(GO:0036490) regulation of translation initiation in response to endoplasmic reticulum stress(GO:0036491) eiF2alpha phosphorylation in response to endoplasmic reticulum stress(GO:0036492) |
0.0 | 0.0 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.0 | 0.3 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.0 | 0.0 | GO:0002604 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.0 | 0.0 | GO:0090656 | t-circle formation(GO:0090656) |
0.0 | 0.1 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.0 | 0.1 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.0 | 0.0 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.0 | 0.2 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.0 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
0.0 | 0.0 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.0 | 0.0 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.0 | 0.0 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.0 | 0.1 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.0 | 0.1 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.0 | 0.1 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.0 | 0.2 | GO:0036093 | germ cell proliferation(GO:0036093) |
0.0 | 0.0 | GO:0044252 | negative regulation of multicellular organismal metabolic process(GO:0044252) |
0.0 | 1.0 | GO:0010976 | positive regulation of neuron projection development(GO:0010976) |
0.0 | 0.0 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.0 | 0.1 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.0 | 0.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.0 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.0 | 0.0 | GO:0030576 | Cajal body organization(GO:0030576) |
0.0 | 0.0 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.0 | 0.0 | GO:0003416 | endochondral bone growth(GO:0003416) bone growth(GO:0098868) |
0.0 | 0.0 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.0 | 0.1 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.0 | 0.0 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.0 | 0.1 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.0 | 0.1 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.0 | 0.1 | GO:0003222 | ventricular trabecula myocardium morphogenesis(GO:0003222) |
0.0 | 0.0 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.0 | 0.0 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.0 | 0.0 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.0 | 0.1 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.0 | 0.1 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.0 | 0.1 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.0 | 0.0 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.0 | 0.0 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.0 | 0.0 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.0 | 0.1 | GO:0018904 | ether metabolic process(GO:0018904) |
0.0 | 0.1 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.0 | 0.1 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.0 | 0.1 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.0 | 0.0 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.0 | 0.1 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.0 | 0.0 | GO:0001927 | exocyst assembly(GO:0001927) |
0.0 | 0.1 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.0 | 0.0 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.0 | 0.2 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
0.0 | 0.1 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
0.0 | 0.0 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
0.0 | 0.0 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.0 | GO:0015755 | fructose transport(GO:0015755) |
0.0 | 0.1 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.0 | 0.6 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
0.0 | 0.0 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.0 | 0.0 | GO:0031279 | regulation of cyclase activity(GO:0031279) |
0.0 | 0.3 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.1 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.0 | 0.4 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.0 | 0.1 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.0 | 0.0 | GO:1903202 | negative regulation of oxidative stress-induced cell death(GO:1903202) |
0.0 | 0.2 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.2 | GO:0006903 | vesicle targeting(GO:0006903) |
0.0 | 0.0 | GO:0002840 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.0 | 0.0 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.0 | 0.0 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.0 | 0.0 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.0 | 0.2 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.1 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.0 | 0.1 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.0 | 0.0 | GO:0035826 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
0.0 | 0.0 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.0 | 0.0 | GO:0061727 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.0 | 0.1 | GO:0009074 | aromatic amino acid family catabolic process(GO:0009074) |
0.0 | 0.0 | GO:0044597 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.0 | 0.1 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
0.0 | 0.4 | GO:0045010 | actin nucleation(GO:0045010) |
0.0 | 0.0 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.0 | 0.0 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.0 | 0.0 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.0 | 0.2 | GO:0050806 | positive regulation of synaptic transmission(GO:0050806) |
0.0 | 0.0 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.0 | 0.1 | GO:0038179 | neurotrophin signaling pathway(GO:0038179) |
0.0 | 0.1 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.1 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
0.0 | 0.0 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 0.0 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.0 | 0.1 | GO:0007613 | memory(GO:0007613) |
0.0 | 0.0 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.0 | 0.1 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.0 | 0.0 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.0 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.0 | 0.0 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.0 | 0.0 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.0 | 0.0 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.0 | 0.1 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.0 | 0.1 | GO:0003334 | keratinocyte development(GO:0003334) |
0.0 | 0.1 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.0 | 0.0 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.0 | 0.0 | GO:0002225 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antibacterial peptide production(GO:0002803) |
0.0 | 0.4 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.1 | GO:0006921 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.0 | 0.0 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.0 | 0.0 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.0 | 0.0 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.0 | 0.0 | GO:0060618 | nipple development(GO:0060618) |
0.0 | 0.1 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.0 | 0.0 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.0 | 0.3 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.0 | 0.1 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.0 | 0.0 | GO:1901535 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.0 | 0.1 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.0 | 0.0 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.0 | 0.1 | GO:0034311 | diol metabolic process(GO:0034311) |
0.0 | 0.0 | GO:0021536 | diencephalon development(GO:0021536) |
0.0 | 0.1 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.0 | 0.0 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 0.0 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.0 | 0.0 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.0 | 0.0 | GO:0090237 | regulation of arachidonic acid secretion(GO:0090237) |
0.0 | 0.0 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.0 | 0.1 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.0 | 0.0 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.0 | 0.1 | GO:0006999 | nuclear pore organization(GO:0006999) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 6.9 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
1.5 | 7.7 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
1.5 | 4.5 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
1.3 | 10.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
1.0 | 4.1 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.9 | 47.5 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.9 | 2.8 | GO:0097441 | basilar dendrite(GO:0097441) |
0.9 | 1.8 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.9 | 4.5 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.8 | 4.8 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.8 | 8.6 | GO:0035102 | PRC1 complex(GO:0035102) |
0.8 | 6.8 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.7 | 12.8 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.7 | 8.5 | GO:0043194 | axon initial segment(GO:0043194) |
0.7 | 4.8 | GO:0032584 | growth cone membrane(GO:0032584) |
0.7 | 5.2 | GO:0071437 | invadopodium(GO:0071437) |
0.6 | 29.8 | GO:0043198 | dendritic shaft(GO:0043198) |
0.6 | 4.7 | GO:0031527 | filopodium membrane(GO:0031527) |
0.6 | 5.8 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.5 | 6.9 | GO:0071565 | nBAF complex(GO:0071565) |
0.5 | 10.1 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.4 | 4.5 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.4 | 10.2 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.4 | 1.4 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.3 | 0.7 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.3 | 3.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.3 | 5.2 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.3 | 2.2 | GO:0030673 | axolemma(GO:0030673) |
0.3 | 4.2 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.3 | 13.0 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.3 | 0.8 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.3 | 35.3 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.3 | 0.8 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.3 | 2.3 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.2 | 0.5 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.2 | 0.5 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.2 | 2.4 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.2 | 0.5 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.2 | 1.6 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.2 | 0.7 | GO:0097427 | microtubule bundle(GO:0097427) |
0.2 | 1.1 | GO:0097433 | dense body(GO:0097433) |
0.2 | 1.7 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.2 | 2.5 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.2 | 0.8 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.2 | 1.9 | GO:0032433 | filopodium tip(GO:0032433) |
0.2 | 3.5 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.2 | 0.8 | GO:0042583 | chromaffin granule(GO:0042583) |
0.2 | 3.5 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.2 | 0.8 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.2 | 0.2 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.2 | 0.6 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.2 | 1.3 | GO:0070852 | cell body fiber(GO:0070852) |
0.2 | 1.8 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.2 | 1.1 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.2 | 1.6 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 0.9 | GO:0005883 | neurofilament(GO:0005883) |
0.2 | 0.5 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.2 | 1.0 | GO:0045180 | basal cortex(GO:0045180) |
0.2 | 0.3 | GO:0097443 | sorting endosome(GO:0097443) |
0.2 | 3.4 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.2 | 0.5 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.2 | 0.8 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.2 | 0.5 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.2 | 7.4 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.2 | 2.7 | GO:0044295 | axonal growth cone(GO:0044295) |
0.2 | 2.7 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 13.3 | GO:0043679 | axon terminus(GO:0043679) |
0.1 | 0.7 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.1 | 0.6 | GO:0000938 | GARP complex(GO:0000938) |
0.1 | 1.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 18.6 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 1.1 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 0.9 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 1.8 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 1.3 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.1 | 3.2 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 0.5 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 0.2 | GO:0000322 | storage vacuole(GO:0000322) |
0.1 | 0.5 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.1 | 0.3 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 1.3 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 7.3 | GO:0030426 | growth cone(GO:0030426) |
0.1 | 0.2 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.4 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 0.3 | GO:1990130 | Iml1 complex(GO:1990130) |
0.1 | 5.7 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 1.8 | GO:0097060 | synaptic membrane(GO:0097060) |
0.1 | 0.2 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 0.3 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 0.4 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 0.9 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 0.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 0.5 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 0.3 | GO:0031417 | NatC complex(GO:0031417) |
0.1 | 0.1 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 0.3 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.1 | 0.3 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 0.5 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 0.2 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.1 | 1.6 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 0.3 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.1 | 0.9 | GO:0031011 | Ino80 complex(GO:0031011) |
0.1 | 0.3 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.3 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 0.4 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 0.3 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 0.4 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.1 | 1.9 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 0.6 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 0.8 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 0.6 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 0.1 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 0.3 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 1.2 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.1 | 0.4 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 0.1 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 0.1 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.1 | 0.4 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.3 | GO:0032590 | dendrite membrane(GO:0032590) |
0.1 | 0.3 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.1 | 2.7 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.1 | 0.3 | GO:0001652 | granular component(GO:0001652) |
0.1 | 0.2 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.2 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.1 | 0.2 | GO:0005767 | secondary lysosome(GO:0005767) |
0.1 | 0.7 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 0.3 | GO:0001940 | male pronucleus(GO:0001940) |
0.1 | 0.2 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 0.1 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.1 | 0.6 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 0.2 | GO:0097449 | astrocyte projection(GO:0097449) |
0.1 | 18.5 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 5.9 | GO:0030424 | axon(GO:0030424) |
0.1 | 0.3 | GO:0005638 | lamin filament(GO:0005638) |
0.1 | 0.2 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 0.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 12.4 | GO:0045202 | synapse(GO:0045202) |
0.1 | 0.2 | GO:0032021 | NELF complex(GO:0032021) |
0.1 | 1.0 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 0.0 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.0 | 0.7 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 0.5 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 0.1 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.0 | 0.3 | GO:0044292 | dendrite terminus(GO:0044292) |
0.0 | 0.3 | GO:0031931 | TORC1 complex(GO:0031931) |
0.0 | 0.1 | GO:0005745 | m-AAA complex(GO:0005745) |
0.0 | 1.2 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.1 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.0 | 0.2 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.0 | 0.3 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.0 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.0 | 1.3 | GO:0032040 | small-subunit processome(GO:0032040) |
0.0 | 0.2 | GO:0089701 | U2AF(GO:0089701) |
0.0 | 0.1 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.0 | 0.2 | GO:0030914 | STAGA complex(GO:0030914) |
0.0 | 1.7 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.6 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 0.3 | GO:0031512 | motile primary cilium(GO:0031512) |
0.0 | 0.2 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.0 | 0.5 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.1 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.0 | 0.2 | GO:0033263 | CORVET complex(GO:0033263) |
0.0 | 0.1 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.0 | 0.2 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 0.1 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.0 | 0.1 | GO:0031313 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.0 | 0.1 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.0 | 0.0 | GO:0005687 | U4 snRNP(GO:0005687) |
0.0 | 0.2 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 0.2 | GO:0060091 | kinocilium(GO:0060091) |
0.0 | 0.1 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.0 | GO:0030689 | Noc complex(GO:0030689) |
0.0 | 0.4 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 0.2 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.0 | 0.2 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.0 | 0.5 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.1 | GO:0005827 | polar microtubule(GO:0005827) |
0.0 | 0.1 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 0.1 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.0 | 0.4 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.0 | 0.2 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 0.2 | GO:0000124 | SAGA complex(GO:0000124) |
0.0 | 0.2 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.0 | 0.4 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 0.0 | GO:0000125 | PCAF complex(GO:0000125) |
0.0 | 0.1 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.0 | 0.3 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.0 | 0.0 | GO:0070820 | tertiary granule(GO:0070820) |
0.0 | 0.1 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.0 | 2.3 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.0 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.0 | 0.2 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.0 | 0.1 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.0 | 0.1 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 0.1 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.0 | 0.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.1 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.0 | 0.1 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.0 | 0.0 | GO:0001939 | female pronucleus(GO:0001939) |
0.0 | 0.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 0.6 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.0 | 0.5 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.0 | 0.2 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 0.1 | GO:0034709 | methylosome(GO:0034709) |
0.0 | 0.7 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 1.0 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.1 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.0 | 0.1 | GO:0097546 | ciliary base(GO:0097546) |
0.0 | 0.1 | GO:0035339 | SPOTS complex(GO:0035339) |
0.0 | 0.1 | GO:0043293 | apoptosome(GO:0043293) |
0.0 | 0.0 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.0 | 0.1 | GO:0000801 | central element(GO:0000801) |
0.0 | 0.3 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.0 | GO:0070461 | SAGA-type complex(GO:0070461) |
0.0 | 0.1 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.0 | 0.0 | GO:0097413 | Lewy body(GO:0097413) |
0.0 | 0.2 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.0 | 0.4 | GO:0034704 | calcium channel complex(GO:0034704) |
0.0 | 0.1 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 0.0 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.0 | 0.2 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.0 | 2.4 | GO:0043005 | neuron projection(GO:0043005) |
0.0 | 0.0 | GO:0031298 | replication fork protection complex(GO:0031298) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.2 | 12.6 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
3.1 | 12.5 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
2.4 | 7.3 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
2.0 | 9.8 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
1.9 | 5.8 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.6 | 4.8 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
1.6 | 6.3 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
1.5 | 4.5 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
1.4 | 8.5 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
1.4 | 8.3 | GO:0048495 | Roundabout binding(GO:0048495) |
1.1 | 4.6 | GO:0005042 | netrin receptor activity(GO:0005042) |
1.1 | 7.9 | GO:0003680 | AT DNA binding(GO:0003680) |
1.0 | 5.0 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
1.0 | 1.0 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.9 | 2.7 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.9 | 3.5 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.8 | 16.7 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.8 | 5.3 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.7 | 2.2 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.7 | 1.4 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.7 | 2.2 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.7 | 3.5 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.7 | 5.3 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.6 | 3.9 | GO:0016595 | glutamate binding(GO:0016595) |
0.6 | 5.5 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.6 | 3.6 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.6 | 3.5 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.6 | 1.7 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.6 | 4.5 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.6 | 1.7 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.6 | 2.2 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.5 | 4.9 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.5 | 1.1 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.5 | 2.2 | GO:0019808 | polyamine binding(GO:0019808) |
0.5 | 7.6 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.5 | 6.3 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.5 | 4.0 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.5 | 1.9 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.5 | 1.4 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.4 | 1.3 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.4 | 10.3 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.4 | 7.7 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.4 | 8.8 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.4 | 7.8 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.4 | 2.0 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.4 | 1.6 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.4 | 0.4 | GO:0038191 | neuropilin binding(GO:0038191) |
0.4 | 1.9 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.4 | 1.2 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.4 | 4.0 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.4 | 1.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.4 | 1.1 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.3 | 7.5 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.3 | 1.4 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.3 | 1.7 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.3 | 3.9 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.3 | 1.3 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.3 | 1.6 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.3 | 3.8 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.3 | 8.2 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.3 | 0.6 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.3 | 2.7 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.3 | 0.9 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.3 | 1.2 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.3 | 0.3 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.3 | 7.4 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.3 | 1.7 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.3 | 0.8 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.3 | 1.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.3 | 1.1 | GO:0030911 | TPR domain binding(GO:0030911) |
0.3 | 3.5 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.3 | 0.8 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.3 | 6.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.3 | 0.8 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.3 | 0.8 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.3 | 2.8 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.3 | 2.5 | GO:0048156 | tau protein binding(GO:0048156) |
0.3 | 8.6 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.2 | 1.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 0.7 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.2 | 0.7 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.2 | 6.4 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.2 | 0.2 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.2 | 1.6 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.2 | 2.7 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.2 | 1.3 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.2 | 0.9 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.2 | 0.6 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.2 | 2.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 4.7 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.2 | 0.2 | GO:0016015 | morphogen activity(GO:0016015) |
0.2 | 1.2 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.2 | 4.4 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.2 | 4.8 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
0.2 | 0.6 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.2 | 2.2 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.2 | 0.8 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.2 | 1.6 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.2 | 1.4 | GO:0036122 | BMP binding(GO:0036122) |
0.2 | 2.2 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.2 | 0.6 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.2 | 1.0 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.2 | 1.0 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.2 | 3.1 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.2 | 1.5 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.2 | 2.4 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.2 | 0.5 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.2 | 1.6 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.2 | 2.1 | GO:0031005 | filamin binding(GO:0031005) |
0.2 | 1.4 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.2 | 1.7 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.2 | 2.3 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.2 | 0.7 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.2 | 0.5 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.2 | 1.6 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.2 | 0.6 | GO:1990254 | keratin filament binding(GO:1990254) |
0.2 | 0.6 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.2 | 1.5 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.2 | 2.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.2 | 1.2 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.2 | 0.3 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.2 | 0.9 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.1 | 0.6 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.1 | 0.7 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 0.9 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 0.4 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.1 | 2.0 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 10.2 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.1 | 0.4 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.1 | 0.4 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 0.7 | GO:0043830 | 4-methyloctanoyl-CoA dehydrogenase activity(GO:0034580) naphthyl-2-methyl-succinyl-CoA dehydrogenase activity(GO:0034845) 2-methylhexanoyl-CoA dehydrogenase activity(GO:0034916) propionyl-CoA dehydrogenase activity(GO:0043820) thiol-driven fumarate reductase activity(GO:0043830) coenzyme F420-dependent 2,4,6-trinitrophenol reductase activity(GO:0052758) coenzyme F420-dependent 2,4,6-trinitrophenol hydride reductase activity(GO:0052759) coenzyme F420-dependent 2,4-dinitrophenol reductase activity(GO:0052760) |
0.1 | 2.0 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.1 | 1.3 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.4 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.1 | 0.7 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 1.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.8 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 0.5 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.1 | 0.5 | GO:0030955 | potassium ion binding(GO:0030955) |
0.1 | 2.9 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.7 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.1 | 0.7 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 1.5 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 1.3 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 2.1 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.1 | 0.2 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.1 | 0.5 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 0.5 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.1 | 4.5 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.1 | 1.5 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.8 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.1 | 0.4 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.1 | 1.1 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.1 | 0.1 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.1 | 0.4 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.1 | 3.8 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 0.6 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 0.3 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 0.3 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 6.2 | GO:0019905 | syntaxin binding(GO:0019905) |
0.1 | 2.1 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.1 | 1.0 | GO:0015254 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.1 | 1.8 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 1.3 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 0.9 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 0.5 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.1 | 0.4 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 1.1 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 3.7 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.1 | 0.4 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 1.1 | GO:0033558 | protein deacetylase activity(GO:0033558) |
0.1 | 0.2 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.1 | 0.7 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 2.5 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.1 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.1 | 0.3 | GO:0005272 | sodium channel activity(GO:0005272) |
0.1 | 0.8 | GO:0030506 | ankyrin binding(GO:0030506) |
0.1 | 0.2 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.1 | 0.4 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.1 | 0.5 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 0.3 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 0.4 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 2.6 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.1 | 0.2 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.1 | 0.7 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 0.5 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 0.3 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 0.4 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.1 | 3.9 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 0.2 | GO:0045340 | mercury ion binding(GO:0045340) |
0.1 | 11.7 | GO:0003729 | mRNA binding(GO:0003729) |
0.1 | 0.5 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.1 | 0.2 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.1 | 0.2 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.1 | 0.5 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 2.0 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 0.5 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 1.9 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.1 | 0.7 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.1 | 2.3 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.2 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 1.1 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.1 | 1.5 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.2 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.1 | 0.3 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 0.3 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.1 | 0.2 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.1 | 0.5 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.1 | 1.2 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.1 | 0.3 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 0.3 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 0.7 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.1 | 0.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 0.7 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.1 | 0.1 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.1 | 0.9 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.1 | 1.3 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.1 | 0.1 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.1 | 0.2 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.2 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.1 | 0.3 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.1 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.1 | 0.2 | GO:0031014 | troponin T binding(GO:0031014) |
0.1 | 1.4 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 0.1 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.1 | 0.2 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.1 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 0.1 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.1 | 0.4 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.1 | 0.2 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 0.4 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.8 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.3 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 0.9 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 0.2 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 0.1 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.1 | 12.8 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.1 | 0.1 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.1 | 0.8 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 2.1 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 0.8 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.2 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.1 | 0.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.5 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 0.3 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.2 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 0.2 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.1 | 1.1 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 1.2 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.1 | 15.1 | GO:0000977 | RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) |
0.1 | 0.1 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.1 | 0.2 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.1 | 0.1 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
0.1 | 0.2 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.1 | 0.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 0.4 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.2 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.1 | 0.1 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.1 | 0.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.2 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.1 | 0.2 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.1 | 0.3 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 0.7 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 0.2 | GO:0004083 | bisphosphoglycerate 2-phosphatase activity(GO:0004083) |
0.1 | 0.1 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.1 | 0.4 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.2 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.1 | 0.6 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 0.2 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.0 | 0.2 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.0 | 0.2 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.0 | 0.2 | GO:0033265 | choline binding(GO:0033265) |
0.0 | 0.1 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.0 | 2.2 | GO:0008907 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.0 | 0.1 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.0 | 2.1 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.6 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 0.7 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.2 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.2 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.0 | 0.4 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.0 | 0.2 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.0 | 0.2 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.0 | 1.7 | GO:0000049 | tRNA binding(GO:0000049) |
0.0 | 0.5 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.0 | 0.2 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.0 | 0.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.0 | 0.9 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.1 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.0 | 0.2 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.0 | 0.3 | GO:0035473 | lipase binding(GO:0035473) |
0.0 | 12.3 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
0.0 | 0.0 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.0 | 0.2 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.0 | 0.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.4 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.2 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.0 | 0.1 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.0 | 1.1 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.0 | 0.0 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.0 | 1.1 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 0.1 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.0 | 0.1 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.0 | 0.1 | GO:0015232 | heme transporter activity(GO:0015232) |
0.0 | 0.0 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.0 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.0 | 0.2 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 0.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.0 | 0.1 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 0.1 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.0 | 0.1 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.0 | 0.1 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.0 | 0.1 | GO:2001070 | starch binding(GO:2001070) |
0.0 | 0.1 | GO:0051998 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
0.0 | 2.5 | GO:0044212 | transcription regulatory region DNA binding(GO:0044212) |
0.0 | 0.2 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.0 | 0.1 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.0 | 0.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.0 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.0 | 0.1 | GO:0089720 | caspase binding(GO:0089720) |
0.0 | 1.1 | GO:0005262 | calcium channel activity(GO:0005262) |
0.0 | 0.0 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.0 | 0.1 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.0 | 0.1 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.0 | 0.2 | GO:0048038 | quinone binding(GO:0048038) |
0.0 | 0.1 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.0 | 0.1 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.0 | 0.1 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.0 | 0.1 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.0 | 0.1 | GO:0019862 | IgA binding(GO:0019862) |
0.0 | 0.1 | GO:0004096 | catalase activity(GO:0004096) |
0.0 | 0.6 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.3 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.0 | 0.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 0.3 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.0 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.1 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.0 | 0.1 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.0 | 0.1 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.0 | 0.1 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.0 | 0.1 | GO:0004337 | geranyltranstransferase activity(GO:0004337) |
0.0 | 0.7 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.0 | 0.1 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.0 | 0.3 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.1 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.0 | 0.4 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.3 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.2 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.0 | 1.0 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.0 | 1.3 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.0 | 0.1 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.0 | 0.0 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.0 | 0.2 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.0 | 0.4 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.2 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 0.1 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.0 | 0.1 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.0 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.0 | 0.1 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.0 | 0.1 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.0 | 0.2 | GO:0070402 | NADPH binding(GO:0070402) |
0.0 | 0.2 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.0 | 0.1 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.0 | 0.1 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.0 | 0.3 | GO:0015026 | coreceptor activity(GO:0015026) |
0.0 | 0.1 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.2 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.0 | 0.1 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.0 | 0.1 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.0 | 0.0 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.0 | 0.2 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 0.2 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.1 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.2 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.0 | 0.1 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.1 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.0 | 0.3 | GO:0034792 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.0 | 0.4 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.0 | 0.0 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.0 | 0.2 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.0 | 0.5 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.0 | 0.1 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.0 | 0.1 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.0 | 0.1 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.0 | 0.6 | GO:0018731 | prenylcysteine methylesterase activity(GO:0010296) 1-oxa-2-oxocycloheptane lactonase activity(GO:0018731) sulfolactone hydrolase activity(GO:0018732) 3,4-dihydrocoumarin hydrolase activity(GO:0018733) butyrolactone hydrolase activity(GO:0018734) endosulfan lactone lactonase activity(GO:0034892) L-ascorbate 6-phosphate lactonase activity(GO:0035460) Ser-tRNA(Thr) hydrolase activity(GO:0043905) Ala-tRNA(Pro) hydrolase activity(GO:0043906) Cys-tRNA(Pro) hydrolase activity(GO:0043907) Ser(Gly)-tRNA(Ala) hydrolase activity(GO:0043908) all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity(GO:0047376) mannosyl-oligosaccharide 1,6-alpha-mannosidase activity(GO:0052767) mannosyl-oligosaccharide 1,3-alpha-mannosidase activity(GO:0052768) methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.0 | 0.1 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.0 | 0.2 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.0 | 0.1 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.0 | 0.1 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.0 | 0.0 | GO:0032357 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.0 | 0.0 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.0 | 0.2 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.0 | 0.0 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.0 | 0.2 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.0 | 0.1 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.0 | 0.1 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 0.1 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.0 | 0.1 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.1 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.0 | 1.0 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.0 | 0.0 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.0 | 0.0 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.0 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.0 | 0.2 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.0 | 0.2 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.2 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.0 | GO:0008556 | potassium-transporting ATPase activity(GO:0008556) |
0.0 | 0.2 | GO:0018451 | C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity(GO:0000252) mevaldate reductase activity(GO:0004495) gluconate dehydrogenase activity(GO:0008875) epoxide dehydrogenase activity(GO:0018451) 5-exo-hydroxycamphor dehydrogenase activity(GO:0018452) 2-hydroxytetrahydrofuran dehydrogenase activity(GO:0018453) acetoin dehydrogenase activity(GO:0019152) phenylcoumaran benzylic ether reductase activity(GO:0032442) D-xylose:NADP reductase activity(GO:0032866) L-arabinose:NADP reductase activity(GO:0032867) D-arabinitol dehydrogenase, D-ribulose forming (NADP+) activity(GO:0033709) (R)-(-)-1,2,3,4-tetrahydronaphthol dehydrogenase activity(GO:0034831) 3-hydroxymenthone dehydrogenase activity(GO:0034840) very long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0035380) (R)-2-hydroxyisocaproate dehydrogenase activity(GO:0043713) L-arabinose 1-dehydrogenase (NADP+) activity(GO:0044103) L-xylulose reductase (NAD+) activity(GO:0044105) 3-ketoglucose-reductase activity(GO:0048258) D-arabinitol dehydrogenase, D-xylulose forming (NADP+) activity(GO:0052677) |
0.0 | 0.0 | GO:0018558 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.0 | 0.2 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.3 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.0 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.0 | 0.0 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.0 | 0.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.0 | 0.0 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 0.0 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.0 | 0.2 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.0 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.0 | 0.0 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.0 | 0.1 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.0 | 0.0 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.0 | 0.0 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.0 | 0.0 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.0 | 0.1 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
0.0 | 0.1 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.1 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.0 | 0.0 | GO:0030519 | snoRNP binding(GO:0030519) |
0.0 | 0.1 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 0.3 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.1 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 0.0 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.0 | 0.0 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.0 | 0.0 | GO:0008425 | C-methyltransferase activity(GO:0008169) 2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity(GO:0008425) quinone cofactor methyltransferase activity(GO:0030580) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 0.8 | PID INSULIN PATHWAY | Insulin Pathway |
0.6 | 9.6 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.3 | 11.6 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.3 | 7.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.3 | 7.8 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.3 | 2.3 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 8.0 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.2 | 9.0 | PID LKB1 PATHWAY | LKB1 signaling events |
0.2 | 4.4 | PID REELIN PATHWAY | Reelin signaling pathway |
0.2 | 1.5 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.2 | 0.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 5.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.2 | 0.9 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.2 | 0.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 1.6 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 2.8 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 3.3 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 3.2 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 1.6 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 0.7 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 1.3 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 3.8 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 2.0 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 0.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 1.0 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 0.1 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 1.2 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 3.2 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.1 | 0.2 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 0.1 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 2.1 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 2.3 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 0.5 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 0.3 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.3 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.8 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 2.2 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 3.1 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 1.6 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 2.0 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.8 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.7 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.5 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.0 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.8 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.3 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.3 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.5 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.0 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 3.4 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.1 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 0.2 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 0.2 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 0.1 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 0.0 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.0 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.1 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.1 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 0.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.0 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.1 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.2 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.2 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 14.8 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
1.4 | 20.4 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.9 | 9.8 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.8 | 7.0 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.6 | 8.0 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.6 | 0.6 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.5 | 7.7 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.5 | 6.4 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.4 | 3.9 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.4 | 4.7 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.4 | 6.8 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.4 | 4.8 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.4 | 1.1 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.4 | 8.6 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.4 | 9.3 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.4 | 1.4 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.4 | 5.6 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.3 | 7.0 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.3 | 7.2 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.3 | 4.0 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.3 | 8.3 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.2 | 3.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.2 | 2.5 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.2 | 4.2 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.2 | 2.2 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.2 | 1.7 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.2 | 4.7 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.2 | 1.4 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.2 | 0.5 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.2 | 1.8 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.2 | 1.9 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.2 | 1.5 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.1 | 0.3 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.1 | 1.1 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.1 | 0.1 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.1 | 6.1 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.1 | 6.5 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 2.3 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 0.8 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.1 | 6.6 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 2.2 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.1 | 1.2 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.1 | 1.4 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 0.6 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 0.3 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.1 | 0.9 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 2.4 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 1.7 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.1 | 0.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 0.4 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 1.7 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.1 | 0.8 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 1.3 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 1.0 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 0.4 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 2.4 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.1 | 0.7 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 0.1 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.1 | 0.2 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.1 | 0.3 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 2.1 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 0.8 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.1 | 0.6 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 0.6 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 0.1 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.1 | 0.7 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 0.6 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.1 | 0.3 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 0.5 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 0.6 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.0 | 0.7 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.0 | 0.5 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 0.4 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.2 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.4 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.0 | 0.9 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.0 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 0.3 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.3 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 0.1 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.0 | 0.1 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 4.4 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.0 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.0 | 0.5 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.0 | REACTOME CYTOKINE SIGNALING IN IMMUNE SYSTEM | Genes involved in Cytokine Signaling in Immune system |
0.0 | 0.7 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.1 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.0 | 0.3 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.5 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.0 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.2 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 0.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.6 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.3 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.6 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.2 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 0.4 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.5 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.0 | 0.1 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.2 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.2 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.0 | 0.2 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.0 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.0 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.6 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.3 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.1 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 0.1 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.0 | 0.1 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.0 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.0 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.3 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 0.4 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |